MRCCC is a 30-story, 375-bed specialist hospital (first phase 100 beds). With the distinction of being the tallest hospital in the Southern Hemisphere and one of top ten tallest hospitals in the world, MRCCC is already a landmark for Jakarta in terms of its height and appearance and an icon for international standard cancer treatment in Asia.
 
MRCCC serves as a Centre of Excellence for Cancer and a Hub for our network of hospitals in cancer treatment with our experienced specialists’ care reaching out to patients living throughout Indonesia. Our focus is to enhance our clinical excellence and leadership in multi- disciplinary, research-driven patient care throughout each phase of the cancer care cycle: education, prevention and early detection, diagnosis and treatment, and survivorship and end-of-life care. As an MRCCC patient, your primary relationship will be with a multi-disciplinary Centre of Excellence, where surgeons, medical oncologists, radiation therapists and other cancer specialists work together under one roof to provide a truly holistic and multi-disciplinary cancer treatment.
 
Conveniently located right at the heart of Jakarta CBD, at the Semanggi interchange, in the prime location of Jakarta, MRCCC’s investment of US$138.8 million includes the most advanced Phillips PET/CT, SPECT/CT, 3 Tesla MRI, 256 Multi-Slice CT Scan and Cathlab, IBA Cyclotron (to produce isotopes) and the Varian Linear Accelerator (LINAC) IX Rapid Arc Supported with CT Simulator. This makes MRCCC the only ‘one-stop’ comprehensive cancer centre in Indonesia. It will also have a fully integrated Nuclear Medicine Department, a first of its kind in Indonesia. When fully commissioned MRCCC will be among the top 10 largest Comprehensive Cancer Centre's in Southeast Asia.

Cancer is one of the leading causes of death in many South East Asian countries and in the world. Nearly 8 million (13% of all deaths) people die worldwide annually as a result of cancer. The top five most common types are lung, breast, colorectal stomach and liver cancers. Worldwide over 10 million people are diagnosed with cancer every year and over 70% of this is in low or middle-income countries like Indonesia. In Indonesia, the prevalence rate of this disease is increasing rapidly and is predicted to be one of the leading causes of death after cardiovascular diseases. Though there is no accurate national prevalence, morbidity and mortality data related to cancer, it is estimated that there will be around 170-190 per 100,000 people of new cancer cases annually, i.e. about 450,000 new cancer patients every year.

Unfortunately, the availability and accessibility to comprehensive cancer treatment services in this country is not sufficient. This has led to a substantial number of Indonesians seeking medical advice and treatment in other countries such as Singapore, China, Australia and the United States. It is estimated that the number of patients  going abroad for medical treatment is over 600,000 people every year, and spending just over US$1.2 billion in foreign expenditure.
 
Now, MRCCC's specialists are at hand to manage the most common cancers found in Indonesia: Cervical, Breast, Liver, Lung, Nasopharynx, Skin, Colorectal, Leukemia, Lymphoma Malginum and Ovarium. Given the rising high incidence of Hepatitis B and C in Indonesia, MRCCC has a dedicated Liver GI Centre to facilitate early detection and accurate prognosis so that you can be given the appropriate care and treatment.
 
MRCCC will also be one of the first in Indonesia to run an integrated computerized and digital information system linking imaging, laboratory, pharmacy and hospital IT services. This will speed up the efficiency and accuracy of service provision with the aim of not only improving the experience to the patient but also facilitating early diagnoses and improved outcomes. Modern IT systems will also help foster research and collaboration within the MRCCC. Siloam Hospitals has invested heavily in recruiting and training Oncology specialists who will be the backbone of the Cancer Centre. They have been sent to countries such as Australia, China, India and Singapore to be trained on latest medical techniques and equipment.
 
MRCCC was commissioned in mid December 2010, involving the simulation of operations to ensure that all the sophisticated state-of-the-art equipment and systems in this complex hospital are integrated for safe and quality delivery of care. A quality of care and service that has never been accessible to a vast majority of Indonesians.